Quick Answer: Zepbound (tirzepatide) can lower A1C levels by 1.9% to 2.4% through its dual GIP and GLP-1 receptor agonist mechanism, though it is FDA-approved only for weight management, not diabetes treatment
Unlike Mounjaro, Wegovy (semaglutide) has no clinically relevant effect on oral contraceptives, in either its injection or pill form
Phase 3 data and practical implications for your protocol Phase 3 data extended the timeline to 68 weeks and pushed peak weight loss to 28.7 percent, equivalent to 71.2 pounds or 32.3 kilograms in the highest-performing participants
Furthermore, it has been shown that physiological high estradiol levels correlate with increased leptin sensitivity and that reduced leptin sensitivity after oophorectomy can be restored with estrogen treatment (154)
Xu P, Yin K, Tang X, Tian J, Zhang Y, Ma J, Xu H, Xu Q, Wang